跳至主要内容

Gene Knockout Technology Service Company

 The Medicilon gene knockout service has been successfully applied to model organisms such as cells, yeast, plants, zebrafish, mice, and rats. Gene knock-out is a technique for the targeted integration of foreign genes into a certain location on the genome of target cells through homologous recombination to achieve the purpose of targeted modification of a gene on a chromosome. It overcomes the blindness and chance of random integration, and is an ideal method to modify and transform biological genetic material.

Gene knockout service

  • 1. CRISPR/Cas9  gene knockout mouse technical service

Technical process: gRNA vector construction =>”gRNA and Cas9 transcribed into mRNA in vitro => “mRNA microinjection (produced by F0 model)

Provide the following technical services:

  •     All-inclusive services from gRNA vector construction to F0 model production

  •     Customers provide Cas9 RNA and gRNA that meet quality requirements for subsequent microinjection and model production

Gene knockout service.png
  • 2. Traditional ES target gene knockout/knock-in mouse technical service

Technical process: Targeting vector design and construction => “ES electrotransfer and positive clone screening => “ES microinjection and chimera preparation =>”F1 generation mouse reproduction and identification

Provide the following technical services: complete gene knockout mice, conditional gene knockout mice, gene knock-in mice

What is a knockout mice model?

After knocking out one or more of all the 30,000 genes in the mouse, the cultured mouse becomes an animal model suitable for drug clinical trials, which can imitate human patients for research and treatment. For example, there is a key link in pharmaceutical research and development, which is animal experiments. In order to study drugs for treating cancer, a mouse model of cancer is required; in order to study diabetes, a mouse model of diabetes is required.

knockout mouse steps
knockout mouse steps

How do you make a knockout mouse?

  1. 1.Obtaining ES cells

  2. 2.Construction of gene vector

  3. 3.Introduction of the target gene

  4. 4.Screen the hit cells with selective medium

  5. 5.By observing the changes in the biological shape of the chimeric mice and then understanding the changes in the biological shape of the mice before and after the change of the target gene, the purpose of studying the target gene is achieved.

Application areas of gene knockout

  1. 1.Establish a transgenic animal model of human diseases to provide materials for medical esearch

  2. 2.Transform animal genotypes, identify new genes and/or their new functions, and study developmental biology

  3. 3.Treatment of genetic diseases

  4. 4.Transform organisms and cultivate new biological varieties

Related Articles:

Knockout Gene Model Has a Nose for Knockout Breath

Distract DNA Repair to Cinch CRISPR Knockout

评论

此博客中的热门博文

Medicilon and Binhui Biopharmaceutical Have Reached a Strategic Collaboration to Jointly Draw a New Blueprint for the Development of New Biological Drugs

  On March 18, Medicilon and Binhui Biopharmaceutical (Binui Bio) announced a strategic collaboration.  The two parties will work together to jointly explore the possibilities in cutting-edge fields such as oncolytic viruses, nucleic acid drugs and protein drugs. Gather and Work Together to Create Advantages      Facilitate the Research and Development of Oncolytic Viruses, Nucleic Acids, Proteins and Other Drugs As a one-stop biopharmaceutical comprehensive preclinical R&D service CRO, Medicilon has been developing and accumulating for 20 years, always adhering to the spirit of innovation, and has successfully constructed bi/multi-specific antibodies,  ADCs ,  mRNA vaccines ,  small nucleic acid drugs ,  PROTAC , and  CGT technical service platform  that have helped 421 INDs obtain clinical approval.  It is this outstanding achievement that has earned Medicilon wide recognition in the industry and laid a solid foundation f...

The Launch Meeting was Held by Medicilon and DAC Biotech of the Contract Research on ADC Preclinical Study

  Chuansha, Shanghai, Nov. 8th, 2019 — Medicilon held the launch meeting with Hangzhou DAC Biotech Co., Ltd to initiate the   preclinical study   of the antibody-drug-conjugate (ADC)  DXC005, including the   pharmacology study ,   DMPK study   and the   safety evaluation . Medicilon has previously completed integrated  preclinical research  on ADC drugs cooperating with DAC Biotech and other companies. Two of them has been approved by NMPA and entered Phase I clinical trials. About Hangzhou DAC Biotech Co., Ltd Hangzhou DAC Biotech, Co., Ltd was officially registered in HEDA Area, Hangzhou City, Zhejiang Province, China around the end of Year 2012, and is located nearby the bank of beautiful Qiantang River. The company focuses on developing conjugate of monoclonal antibody and small molecular cytotoxic drug, both of which are banded together with smart linkers. About Antibody-Drug-Conjugate (ADC) ADCs ...

A Nickel-Catalyzed Reductive Alkylation of Aryl Bromides and Chlorides for Sp3-Sp2 Bond Formation

  In 2012, a nickel-catalyzed reductive alkylation method of aryl bromides and chlorides was reported. Under the optimized conditions, a variety of aryl and vinyl bromides as well as active aryl chloride can be reductively coupled with alkyl bromides in high yields. The protocols were highly functional-group tolerant and the reactions were not air or moisture sensitive. The reaction showed different chemoselectivity than conventional cross-coupling reactions. Substrates bearing both anelectrophilic and nucleophilic carbon resulted in selective coupling at the electrophilic carbon (R-X) and no reaction occurred at the nucleophilic carbon (R-[M]). The 2010 Nobel Prize in Chemistry was awarded for the Pd-catalyzed cross-coupling, and in the past decade the progress in cross-coupling has not only had a significant impact on academic research but has also influenced the industrial synthetic application. The transition-metal-catalyzed union of nucleophilic organo-boronic acids with elect...